$8.3Bn Coronavirus Response Act Lays Out US FDA’s, CDC’s And Localities’ Roles In Fighting Virus
An $8.3bn “Coronavirus Preparedness and Response Supplemental” funding act approved by the US Congress last week and signed into law on 6 March provides dollars and lays out the roles federal agencies, such as the FDA, and state and local agencies must play in containing and controlling the spread of COVID-19.
You may also be interested in...
The US Congress wrapped up work on 18 March on a second COVID-19 preparedness bill to cover costs of testing uninsured individuals, military beneficiaries and other outbreak responses. A planned third COVID-19 relief package would dole out $1tn to agencies and device makers.
Medtech Insight is tracking the IVD companies manufacturing tests for SARS-CoV-2, the coronavirus that causes COVID-19.